HILARY SMITH CONNERY, MD, PHD
- Harvard title(s): Assistant Professor, Harvard Medical School
- McLean title(s): Clinical Director, Alcohol and Drug Abuse Treatment Program
- Email: email@example.com
- Telephone: (617) 855-3881
- Fax: (617) 855-2699
- Office Address: Alcohol and Drug Abuse Treatment Program (ADATP), 115 Mill St., Belmont, MA 02478
- 1996 M.D., Ph.D. (neuroscience), University of North Carolina School of Medicine/Curriculum in Neurobiology
- 1988 B.A. (neurobiology), Cornell University College of Arts and Sciences
- 1996-2000 Massachusetts General Hospital/McLean Hospital Adult Psychiatry Training Program
- 1999-2000 Clinical fellow, Personality Disorders Institute, New York-Presbyterian Hospital
Dr. Connery is board-certified in psychiatry and is Clinical Director, Alcohol and Drug Abuse Treatment Program (ADATP), Division of Alcohol and Drug Abuse (DADA); she also designed and directs the outpatient buprenorphine stabilization program for patients with opioid dependence and co-occurring psychiatric illness and received a Harvard Medical Scholars research award to study treatment outcomes in this population. She is currently a principal investigator for the Harvard University Northern New England Node of the NIDA Clinical Trials Network, part of a national multi-site clinical trial studying outcomes of buprenorphine treatment and counseling for patients with prescription opioid dependence. Prior to that she was a principal investigator for NIDA CTN study of buprenorphine treatment in adolescents and young adults with opioid dependence. Dr. Connery is an author of the American Psychiatric Association Practice Guidelines for treatment of patients with substance use disorders, and a recognized member of Best Doctors in America. She maintains a discreet private practice with adult consultation services and treatment.
- Curriculum vitæ: (PDF format)
- Kleber HD, Weiss RD, Anton RF Jr, George TP, Greenfield SF, Kosten TR, O'Brien CP, Rounsaville BJ, Strain EC, Ziedonis DM, Hennessy G, Connery HS, McIntyre JS, Charles SC, Anzia DJ, Cook IA, Finnerty MT, Johnson BR, Nininger JE, Summergrad P, Woods SM, Yager J, Pyles R, Cross CD, Peele R, Shemo JP, Lurie L, Walker RD, Barnowitz MA, Gray SH, Saxena S, Tonnu T, Kunkle R, Albert AB, Fochtmann LJ, Hart C, Regier D; Work group on Substance Use Disorders; American Psychiatric Association;Steering Committee on Practice Guidelines. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry.2007 Apr;164( 4 Suppl): 5-123.
- Truco EM, Connery HS, Griffin ML, Greenfield SF. The relationship of self esteem and self-efficacy to treatment outcomes of alcohol dependent men and women. Am J Addict. 2007;16(2):85-92.
- Connery HS, McHugh K, Greenfield, SF . How well does AA work? That's (partly) up to you. Current Psychiatry 2005 May 4(5):1-6.